Skip to main content

Articles

Recent Articles

evaluation of immune response following treatment with Anti-CTLA-4 antibody, radiation therapy, or combination in murine model of breast cancer
Articles  —  2 June Jun 2020
Oncology

evaluation of immune response following treatment with Anti-CTLA-4 antibody, radiation therapy, or combination in murine model of breast cancer

Read More about evaluation of immune response following treatment with Anti-CTLA-4 antibody, radiation therapy, or combination in murine model of breast cancer
evaluation of immune response following treatment with Anti-CTLA-4 antibody, radiation therapy, or combination in murine model of breast cancer
Articles  —  2 June Jun 2020
Oncology

evaluation of immune response following treatment with Anti-CTLA-4 antibody, radiation therapy, or combination in murine model of breast cancer

Read More about evaluation of immune response following treatment with Anti-CTLA-4 antibody, radiation therapy, or combination in murine model of breast cancer
New REACH nanomaterial requirements: what you need to do
Articles  —  2 June Jun 2020
Oncology

New REACH nanomaterial requirements: what you need to do

Read More about New REACH nanomaterial requirements: what you need to do
New REACH nanomaterial requirements: what you need to do
Articles  —  2 June Jun 2020
Oncology

New REACH nanomaterial requirements: what you need to do

Read More about New REACH nanomaterial requirements: what you need to do
Pharmacovigilance & risk management for biosimilars: unique challenges & possible solutions
Articles  —  2 June Jun 2020
Oncology

Pharmacovigilance & risk management for biosimilars: unique challenges & possible solutions

Read More about Pharmacovigilance & risk management for biosimilars: unique challenges & possible solutions
Pharmacovigilance & risk management for biosimilars: unique challenges & possible solutions
Articles  —  2 June Jun 2020
Oncology

Pharmacovigilance & risk management for biosimilars: unique challenges & possible solutions

Read More about Pharmacovigilance & risk management for biosimilars: unique challenges & possible solutions
Press Release: LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
Articles  —  28 May May 2020
Oncology

Press Release: LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable

Read More about Press Release: LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
Press Release: LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
Articles  —  28 May May 2020
Oncology

Press Release: LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable

Read More about Press Release: LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests
Articles  —  5 May May 2020
Oncology

Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests

Read More about Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests
Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests
Articles  —  5 May May 2020
Oncology

Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests

Read More about Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests
Real-World Case Studies: Labcorp Functional Service Provider (FSPx) Model
Articles  —  4 May May 2020
Oncology

Real-World Case Studies: Labcorp Functional Service Provider (FSPx) Model

Read More about Real-World Case Studies: Labcorp Functional Service Provider (FSPx) Model
Real-World Case Studies: Labcorp Functional Service Provider (FSPx) Model
Articles  —  4 May May 2020
Oncology

Real-World Case Studies: Labcorp Functional Service Provider (FSPx) Model

Read More about Real-World Case Studies: Labcorp Functional Service Provider (FSPx) Model